David A. Six

5.0k total citations · 1 hit paper
49 papers, 2.8k citations indexed

About

David A. Six is a scholar working on Molecular Biology, Molecular Medicine and Genetics. According to data from OpenAlex, David A. Six has authored 49 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Molecular Medicine and 20 papers in Genetics. Recurrent topics in David A. Six's work include Antibiotic Resistance in Bacteria (23 papers), Bacterial Genetics and Biotechnology (17 papers) and Escherichia coli research studies (8 papers). David A. Six is often cited by papers focused on Antibiotic Resistance in Bacteria (23 papers), Bacterial Genetics and Biotechnology (17 papers) and Escherichia coli research studies (8 papers). David A. Six collaborates with scholars based in United States, Greece and Canada. David A. Six's co-authors include Edward A. Dennis, Christian R.H. Raetz, Marian Mosior, Ziqiang Guan, Partho Ghosh, Violetta Constantinou‐Kokotou, Xiaoyuan Wang, Roy Curtiss, George Kokotos and Thomas Krucker and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

David A. Six

47 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The expanding superfamily of phospholipase A2 enzymes: classification and characterization

2000 1.1k citations David A. Six, Edward A. Dennis Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Six United States	23	1.6k	766	421	320	278	49	2.8k
Xavier Robert France	14	3.6k 2.3×	618 0.8×	243 0.6×	216 0.7×	238 0.9×	42	5.8k
Stéphane Canaan France	33	1.6k 1.0×	403 0.5×	252 0.6×	203 0.6×	188 0.7×	88	3.3k
Xuejun C. Zhang China	38	2.5k 1.5×	657 0.9×	272 0.6×	169 0.5×	129 0.5×	108	4.4k
Adrian R. Walmsley United Kingdom	34	1.8k 1.2×	398 0.5×	451 1.1×	227 0.7×	137 0.5×	89	3.6k
Matthew W. Frank United States	30	1.7k 1.1×	419 0.5×	257 0.6×	162 0.5×	72 0.3×	63	2.9k
Young Ho Jeon South Korea	31	2.6k 1.6×	423 0.6×	122 0.3×	237 0.7×	92 0.3×	124	3.5k
Sandhya S. Visweswariah India	34	2.0k 1.3×	507 0.7×	132 0.3×	108 0.3×	306 1.1×	138	3.4k
Joanna Betts United Kingdom	26	1.9k 1.2×	416 0.5×	418 1.0×	240 0.8×	72 0.3×	37	3.9k
Focco van den Akker United States	33	1.6k 1.0×	205 0.3×	962 2.3×	606 1.9×	409 1.5×	80	3.3k
Lothar Jänsch Germany	37	3.6k 2.3×	492 0.6×	363 0.9×	86 0.3×	328 1.2×	116	5.2k

Countries citing papers authored by David A. Six

Since Specialization

Citations

This map shows the geographic impact of David A. Six's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Six with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Six more than expected).

Fields of papers citing papers by David A. Six

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Six. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Six. The network helps show where David A. Six may publish in the future.

Co-authorship network of co-authors of David A. Six

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Six. A scholar is included among the top collaborators of David A. Six based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Six. David A. Six is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mack, Andrew R, Vijay Kumar, Christopher R. Bethel, et al.. (2025). Structure and mechanism of taniborbactam inhibition of the cefepime-hydrolyzing, partial R2-loop deletion Pseudomonas -derived cephalosporinase variant PDC-88. Antimicrobial Agents and Chemotherapy. 69(7). e0007825–e0007825. 1 indexed citations

Uehara, Tsuyoshi, John L. Colombo, David A. Six, et al.. (2025). Spectrum of cefepime-taniborbactam coverage against 190 β-lactamases defined in engineered isogenic Escherichia coli strains. Antimicrobial Agents and Chemotherapy. 69(5). e0169924–e0169924. 2 indexed citations

Jacobs, Michael R., Caryn E. Good, Ayman M. Abdelhamed, et al.. (2024). ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten. Antimicrobial Agents and Chemotherapy. 68(12). e0112724–e0112724.

Jacobs, Michael R., Ayman M. Abdelhamed, Caryn E. Good, et al.. (2024). ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrobial Agents and Chemotherapy. 68(9). e0075124–e0075124. 6 indexed citations

Karlowsky, James A., Mark G. Wise, Meredith Hackel, et al.. (2024). Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22. Journal of Antimicrobial Chemotherapy. 79(12). 3116–3131. 12 indexed citations

Mojica, María F., et al.. (2024). Cefepime-taniborbactam demonstrates potent in vitro activity vs Enterobacterales with bla _OXA-48. Microbiology Spectrum. 12(11). e0114424–e0114424. 1 indexed citations

Kumar, Ashish, Somnath Chakravorty, Brittany L. Nairn, et al.. (2022). Fluorescent sensors of siderophores produced by bacterial pathogens. Journal of Biological Chemistry. 298(3). 101651–101651. 17 indexed citations

Nilsson, Inga Marie, et al.. (2020). Metabolic phospholipid labeling of intact bacteria enables a fluorescence assay that detects compromised outer membranes. Journal of Lipid Research. 61(6). 870–883. 11 indexed citations

Sachdeva, Meena, et al.. (2019). Development and Optimization of a Higher-Throughput Bacterial Compound Accumulation Assay. ACS Infectious Diseases. 5(3). 394–405. 20 indexed citations

10.

Six, David A., Thomas Krucker, & Jennifer A. Leeds. (2018). Advances and challenges in bacterial compound accumulation assays for drug discovery. Current Opinion in Chemical Biology. 44. 9–15. 28 indexed citations

11.

Nilsson, Inga Marie, et al.. (2017). Molecular characterization and verification of azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid incorporation into bacterial lipopolysaccharide. Journal of Biological Chemistry. 292(48). 19840–19848. 30 indexed citations

12.

Six, David A., et al.. (2012). Density gradient enrichment of Escherichia coli lpxL mutants. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(7). 989–993. 1 indexed citations

13.

Kong, Qingke, David A. Six, Qing Liu, et al.. (2011). Palmitoylation State Impacts Induction of Innate and Acquired Immunity by the Salmonella enterica Serovar Typhimurium msbB Mutant. Infection and Immunity. 79(12). 5027–5038. 40 indexed citations

14.

Sun, Wei, et al.. (2011). A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine. 29(16). 2986–2998. 35 indexed citations

15.

Raetz, Christian R.H., Ziqiang Guan, Brian O. Ingram, et al.. (2008). Discovery of new biosynthetic pathways: the lipid A story. Journal of Lipid Research. 50. S103–S108. 173 indexed citations

16.

Karbarz, Mark J., David A. Six, & Christian R.H. Raetz. (2008). Purification and Characterization of the Lipid A 1-Phosphatase LpxE of Rhizobium leguminosarum. Journal of Biological Chemistry. 284(1). 414–425. 22 indexed citations

17.

Constantinou‐Kokotou, Violetta, et al.. (2004). Synthesis and activity of 2-oxoamides containing long chain β-amino acids. Journal of Peptide Science. 11(7). 431–435. 21 indexed citations

18.

Six, David A., et al.. (2003). In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with Phospholipase A2 Inhibitors. Journal of Biological Chemistry. 278(42). 41326–41332. 139 indexed citations

19.

Six, David A. & Edward A. Dennis. (2003). Essential Ca2+-independent Role of the Group IVA Cytosolic Phospholipase A2 C2 Domain for Interfacial Activity. Journal of Biological Chemistry. 278(26). 23842–23850. 65 indexed citations

20.

Mosior, Marian, David A. Six, & Edward A. Dennis. (1998). Group IV Cytosolic Phospholipase A2 Binds with High Affinity and Specificity to Phosphatidylinositol 4,5-Bisphosphate Resulting in Dramatic Increases in Activity. Journal of Biological Chemistry. 273(4). 2184–2191. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact